ArcelorMittal Narrows Losses, Cautions on China

Steel giant ArcelorMittal narrowed its net loss in the first quarter and forecast improved earnings to come as steel prices begin to recover, but cautioned that excess steel capacity in China still remains a concern.

 
Goldman Sachs Cuts More Jobs in its Securities Business

Goldman Sachs is trimming additional staff from its sales and trading division, people familiar with the matter said, marking another wave of cost cuts for the Wall Street firm.

 
China's HNA in Talks to Buy Singapore Logistics Firm

The Chinese conglomerate is in advanced discussions to buy a controlling stake in CWT-something that would trigger an offer for the entire company valued at about US$1 billion.

 
Venezuela Official Sues Dow Jones, News Corp. for Libel

A top government official in Venezuela has sued Dow Jones & Co. Inc. and News Corp. for libel, accusing reporters from The Wall Street Journal of making false allegations about him related to drug trafficking and money laundering.

 
News Corp Reports Loss on Legal Settlement

News Corp swung to a loss in the March quarter, hurt by a legal settlement, turmoil in the advertising markets and foreign-currency fluctuations.

 
Valeant Forms Committee to Determine Drug Prices

Valeant Pharmaceuticals International Inc., which has come under heavy fire from politicians because of dramatic price increases for its drugs, said it had formed a committee that will be responsible for those prices going forward.

 
Herbalife Nears Resolution of FTC Probe

Herbalife Ltd. said it was nearing a resolution to a regulatory investigation into whether the company was operating as a pyramid scheme.

 
LinkedIn Buys Run Hop, Seeks to Make Feeds More Engaging

The professional social network said the acquisition targeted talent instead of technology as LinkedIn invests in content.

 
Endo Cuts Annual Guidance on Impairment Charge

Endo International PLC on Thursday reported its losses deepened in its latest quarter, pressured by an asset impairment charge, leading the pharmaceutical company to cut annual guidance.

(END) Dow Jones Newswires

May 06, 2016 02:51 ET (06:51 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.